Both high and low pre-infection glucose levels associated with increased risk for severe COVID-19: New insights from a population-based study M Shauly-Aharonov, A Shafrir, O Paltiel, R Calderon-Margalit, R Safadi, ... PLoS One 16 (7), e0254847, 2021 | 27 | 2021 |
The Association between Serum Vitamin D Levels and Helicobacter pylori Presence and Eradication A Shafrir, M Shauly-Aharonov, LH Katz, O Paltiel, Y Pickman, Z Ackerman Nutrients 13 (1), 278, 2021 | 21 | 2021 |
Advanced Liver Fibrosis Correlates With Impaired Efficacy of P fizer‐B io NT ech COVID‐19 Vaccine in Medical Employees A Shafrir, J Amer, D Hakimian, Y Milgrom, M Massarwa, W Hazou, A Imam, ... Hepatology Communications 6 (6), 1278-1288, 2022 | 9 | 2022 |
Colonoscopy in nonagenarians is safe and may be associated with clinical benefit A Shafrir, B Koslowsky, D Wengrower, E Goldin, DM Livovsky Journal of the American Geriatrics Society 67 (6), 1158-1163, 2019 | 6 | 2019 |
The association between proton pump inhibitors and COVID-19 is confounded by hyperglycemia in a population-based study A Shafrir, AA Benson, LH Katz, T Hershcovici, M Bitan, O Paltiel, ... Frontiers in Pharmacology 13, 791074, 2022 | 5 | 2022 |
Nonattendance to gastroenterologist follow-up after discharge is associated with a thirty-days re-admission in patients with inflammatory bowel disease: a multicenter study. W Sbeit, T Khoury, A Kadah, A Shahin, A Shafrir, I Kalisky, W Hazou, ... Minerva Medica 112 (4), 467-473, 2021 | 5 | 2021 |
Unawareness of thromboprophylaxis is associated with low venous thromboembolism occurrence in hospitalized patients with acute inflammatory bowel disease flare. W Sbeit, A Kadah, A Shafrir, I Kalisky, M Mahamid, W Hazou, L Katz, ... Minerva Medica 111 (6), 560-565, 2020 | 3 | 2020 |
Myocardial injury induced by the long acting beta2 adrenergic agonist clenbuterol A Shafrir, DW Leibowitz, R Alcalai, Y Elitzur, M Muszkat Cardiol Cardiovasc Med 3 (4), 186-192, 2019 | 3 | 2019 |
Patients with low ALT levels are at increased risk for severe COVID-19 D Genzel, LH Katz, R Safadi, A Rozenberg, Y Milgrom, JM Jacobs, ... Frontiers in Medicine 10, 1231440, 2023 | 2 | 2023 |
Safety of oesophagogastroduodenoscopy in a nonagenarian population R Ellis, DM Livovsky, DS Shapiro, R Friedmann, A Shafrir, E Goldin, ... Age and Ageing 50 (5), 1840-1844, 2021 | 2 | 2021 |
Elderly with advanced liver fibrosis had lower response to Pfizer's SARS-CoV-2 vaccine response D Hakimian, A Shafrir, Y Milgrom, M Masarwa, W Hazou, J Amer, R Safadi JOURNAL OF HEPATOLOGY 75, S220-S220, 2021 | 2 | 2021 |
Low ALT Is Associated with IBD and Disease Activity: Results from a Nationwide Study A Shafrir, LH Katz, M Shauly-Aharonov, A Zinger, R Safadi, J Stokar, ... Journal of Clinical Medicine 13 (7), 1869, 2024 | | 2024 |
TEN-HOUR INTERMITTENT FASTING PLUS MEDITERRANEAN DIET VERSUS MEDITERRANEAN DIET ALONE FOR TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) Y Milgrom, M Massarwa, W Hazou, A Shafrir, E Mishraki, S Sanduka, ... Harefuah 163 (2), 93-96, 2024 | | 2024 |
Weaker SARS-CoV-2 vaccine responses in nonalcoholic fatty liver disease with advanced liver fibrosis D Hakimian, J Amer, A Jammal, A Shafrir, Y Milgrom, M Masarowah, ... Vaccine: X 15, 100359, 2023 | | 2023 |
Long-term benefit of mTOR inhibitors for dropping calcineurin inhibitors in liver transplant recipients Y Milgrom, A Imam, A Jammal, S Shabaneh, J Amer, A Shafrir, ... Journal of Hepatology 78, S484-S485, 2023 | | 2023 |
Real-Life Comparison of Fosfomycin to Nitrofurantoin for the Treatment of Uncomplicated Lower Urinary Tract Infection in Women A Shafrir, Y Oster, M Shauly-Aharonov, J Strahilevitz Biomedicines 11 (4), 1019, 2023 | | 2023 |
SARS-CoV-2 vaccine alleviates disease burden and severity in liver transplant recipients even with low antibody titers A Khalaileh, A Imam, A Jammal, D Hakimian, J Amer, A Shafrir, Y Milgrom, ... Hepatology Communications 7 (2), e0025, 2023 | | 2023 |
P539 COVID-19 is Associated with Long-term Elevated Fecal Calprotectin Levels in Patients with Crohn’s Disease but not in Ulcerative Colitis KL Shafrir Asher, Benson Ariel, Zinger Adar, Shauly Aharonov Michal Journal of Crohn's and Colitis 16 (Issue Supplement 1), i488, 2022 | | 2022 |
P305 Low ALT is more Common in Patients with IBD than Healthy Controls and is Associated with Active Disease A Shafrir, L Katz, A Zinger, R Safadi, I Kaliski Journal of Crohn's and Colitis 16 (Supplement_1), i333-i333, 2022 | | 2022 |
Eligibility for growth hormone therapy in children born small for gestational age is substantially lower than expected E Lavi, A Shafrir, R Halloun, I Basel, S Eventov Friedman, A Abu‐Libdeh, ... Clinical Endocrinology 95 (2), 308-314, 2021 | | 2021 |